(Q50582131)
Statements
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. (English)
1 reference
Barbara S E August-Jörg
1 reference
Jan Borovicka
1 reference
Jean-François Dufour
1 reference
Jean-Jacques Gonvers
1 reference
Samuel Henz
1 reference
Rudolf Hermann
1 reference
Christa Meyenberger
1 reference
Manfred Weitz
1 reference
Eberhard L Renner
1 reference
Swiss Association for the Study of the Liver
1 reference
1 August 2003
1 reference
133
1 reference
33-34
1 reference
455-460
1 reference